Plain-English translation of NCT06596694 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help people with advanced gastrointestinal cancers (cancers of the digestive system that have spread). Researchers want to learn whether this treatment is safe, how well patients tolerate it, and whether it can shrink tumors or stop cancer from growing.
Advanced gastrointestinal cancers are serious and difficult to treat. This trial exists to find out if this new medication could offer hope for patients whose cancers have not responded well to standard treatments or have returned.
If you join this trial, you will receive the medication by IV infusion once every 3 weeks. You will continue receiving treatment unless your cancer progresses, you experience intolerable side effects, or your doctor decides to stop. Throughout the trial, you will have regular visits to check your safety, monitor how your body is responding, and see whether your cancer is shrinking.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States